Combining the MEK1/2 inhibitor PD0325901 with AXL knockdown decreased the proliferation of MPNST cells in vitro and reduced MPNST growth in vivo. The gene discussed is MAP2K1; the disease is malignant peripheral nerve sheath tumor.